Agilent Technologies
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 94.22% -0.01pp
- Institutions
- 1,503 -6
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 17 buys · 28 sells
| Name | Role | Stake |
|---|---|---|
| Robert McMahon | Former Senior Vice President | 0.03% |
| Michael McMullen | Former Chief Executive Officer | 0.07% |
| Henrick Ancher-Jensen | Former Senior VP and President of Order Fulfillment & Supply Chain | 0.03% |
| Padraig McDonnell | Chief Executive Officer | 0.02% |
| Boon Hwee Koh | Former Independent Non-Executive Chairperson | 0.02% |
| Angelica Riemann | Senior VP & President of Agilent CrossLab Group | 0.01% |
| Susan Rataj | Independent Director | 0.01% |
| Dominique Grau | Former Senior Vice President of Human Resources & Global Communications | 0.02% |
| George Scangos | Independent Director | 0.01% |
| Mala Anand | Independent Director | 0.01% |
| Jonah Kirkwood | Senior VP & Chief Commercial Officer of Commercial Organization | 0.00% |
| Jian Zhang | Senior VP & President of Applied Markets Group | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-07 | Glenn Boehnlein | Independent Director | Other Acquisition | +817 | $146.85 |
| 2026-09-03 | G. Dolsten | Independent Director | Open Market Disposition | -634 | $151.38 |
| 2026-09-03 | Glenn Boehnlein | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-06-25 | Jonah Kirkwood | Senior VP & Chief Commercial Officer of Commercial Organization | Sale to Issuer | -30 | $136.01 |
| 2026-06-02 | Padraig McDonnell | Chief Executive Officer | Sale to Issuer | -418 | $137.40 |
| 2026-06-01 | Tim Downs | Vice President | Initial Statement of Beneficial | 0 | -- |
| 2026-05-28 | G. Dolsten | Independent Director | Open Market Disposition | -1,600 | $135.42 |
| 2026-05-18 | Michael Buckner | Chief Legal Officer | Other Acquisition | +8,872 | -- |
| 2026-05-07 | Simon May | Senior VP and President of Life Sciences & Diagnostics Markets Group | Sale to Issuer | -368 | $115.62 |
| 2026-05-03 | Michael Buckner | Chief Legal Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-30 | Meghan Henson | Chief Human Resources Officer | Sale to Issuer | -153 | $113.98 |
| 2026-03-18 | Otis Brawley | Independent Director | Other Acquisition | +3,046 | $111.75 |
| 2026-03-18 | George Scangos | Independent Director | Other Acquisition | +3,215 | $111.75 |
| 2026-03-18 | Dow Wilson | Independent Chairperson | Other Acquisition | +2,158 | $111.75 |
| 2026-03-18 | Boon Hwee Koh | Former Independent Non-Executive Chairperson | Sale to Issuer | -648 | $111.75 |
| 2026-03-18 | Boon Hwee Koh | Former Independent Non-Executive Chairperson | Other Acquisition | +2,158 | $111.75 |
| 2026-03-18 | Pascal Claude Soriot | Independent Director | Sale to Issuer | -648 | $111.75 |
| 2026-03-18 | Pascal Claude Soriot | Independent Director | Other Acquisition | +2,158 | $111.75 |
| 2026-03-18 | Daniel Podolsky | Independent Director | Other Acquisition | +2,158 | $111.75 |
| 2026-03-18 | Judy L. Brown | Independent Director | Other Acquisition | +2,158 | $111.75 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:01:22 · For reference only, not investment advice and not tailored to your situation.
Agilent Technologies discussion 0 comments